Posts Tagged ‘Innovation’
CHF 3 Million for Terapet and two South Korea partners
Terapet SA together with their South Korean partners Yonsei Cancer Center (Heavy Ion Therapy Center) and Oncosoft Inc. are awarded CHF 3 Million in non-dilutive funds through a bilateral innovation project funded by Innosuisse and the Korea Institute for Advancement of Technology (KIAT). Terapet SA, a Geneva-based CERN spin-off developing an innovative platform…
Read MoreA CHF multimillion investment for Mimix Biotherapeutics
Mimix Biotherapeutics in Biel (Bern) secures significant investment to translate and commercialize a new treatment technique for human tissue regeneration. The strategic investors are supporting MimiX’s vision to transform the lives of millions of patients suffering from chronic wounds. The investment will accelerate the development and commercialization of FastSkin®, a revolutionary treatment that…
Read MoreBioArk Monthey: a 3rd building dedicated to life sciences and biotechnologies
BioArk is on a roll! The Monthey-based technology site, which is celebrating its 20th anniversary this year, inaugurated its third building on Friday 13 October 2023. And it is almost already full! This new showcase, which houses companies specialising in life sciences and biotechnology, is already virtually full. It is proof that The…
Read MoreNovostia starts clinical trials of its new heart valve in Lituania
Novostia has received the green light from the Lithuanian State Health Care Accreditation Agency under the Ministry of Health to launch the First-in-Human implantations (FIH) of its aortic heart valve prosthesis: the TRIFLO. These implants are scheduled to begin in December 2023, at Vilnius University Hospital Santaros Klinikos, under the supervision of Professor Kęstutis…
Read MoreCancer Research: ISREC Foundation and EPFL announce the creation of the Paternot Chair
The chair will be held by Professor Nicolas Thomä. The ISREC Foundation is contributing to the funding of the Chair with a donation of CHF 7.5 million. The Chair is named in memory of Yves Paternot, a tireless patron of the arts and President of the ISREC Foundation who passed away in 2016, and whose…
Read MoreAtinary Technologies raises CHF 4.6 Million
The Biopôle-based start-up has developed a machine learning platform dedicated to materials discovery. The seed-round was round led by AgFunder and supported by Cherubic Ventures. Atinary is dedicated to accelerating R&D and discovery across diverse industries, including pharmaceuticals, biotechnology, chemicals, energy, electronics, cosmetics, and food via its cutting-edge, no-code platform SDLabs. This investment will…
Read MoreFuture Health Grant – 9 new projects selected
This great Swiss Health Valley🇨🇭 initiative was started by CSS and EPFL Innovation Park to promote Medicine 3.0. The 9 projects of the new cohort will receive between CHF 10,000 and CHF 50,000 as well as support and coaching. Allians Allergy Allergix – Digital solution enabling healthcare professionals to protect their patients against…
Read MoreFuture Health Lausanne, an opportunity for the Swiss Health Valley
Future Health Lausanne is taking place on 3 October 2023 at the Swisstech Convention Center in Lausanne. The event is a real opportunity to bring together the regional life sciences ecosystem according to Magali Bischof, BioAlps’ Secretary General. Tell us more about the translation ecosystem in the region? The Swiss Health Valley is home…
Read MoreAdiposs SA announced the completion of the phase I clinical trial of its ImageBAT™
Adiposs SA, a Swiss biotech company developing medical imaging products and technologies, announced the completion of the phase I clinical trial of its flagship product, ImageBAT™, a medical imaging product Thirty healthy subjects were given single ascending doses of ImageBAT™. The product demonstrated good tolerability and safety with no serious or severe adverse…
Read MoreA consortium led by Addex Therapeutics secures a €4 million Eurostars grant
The Geneva-based pharmaceutical company will use the grant to support its programme for mild neurocognitive disorders (mNCD). The project, called COGNI+, aims to develop clinical candidates ready for IND enabling studies and is led by a consortium that includes Naason Science (South Korea), BioAxis Research (Netherlands), Pharmidex Pharmaceutical Services (UK), and Stichting Radboud…
Read More